Skip to main content
Clinical and Translational Medicine

Table 3 Number of relapses in each study group during the 12-month study period

From: A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients

Number of relapses

Study groups

Treatment group

Number (%)

Control group

Number (%)

0

25 (100)

0 (0)

1

0 (0)

11 (36.7)

2

0 (0)

19 (63.3)

Back to article page